Published in J Clin Pathol on September 01, 2004
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res (2009) 4.36
Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood (2005) 3.51
Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One (2008) 2.90
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2008) 1.98
Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci U S A (2005) 1.97
Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol (2006) 1.86
CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells (2009) 1.68
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2011) 1.66
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med (2007) 1.48
CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol (2006) 1.36
Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings. FASEB J (2008) 1.36
Concise review: current status of stem cells and regenerative medicine in lung biology and diseases. Stem Cells (2014) 1.21
Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med (2006) 1.18
Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma. BMC Cancer (2010) 1.15
Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury. Respir Res (2007) 1.14
Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS One (2008) 1.14
Bone marrow-derived cell regulation of skeletal muscle regeneration. FASEB J (2008) 1.11
Stem cells and regenerative medicine in lung biology and diseases. Mol Ther (2012) 1.08
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer (2012) 1.02
The role and therapeutic potential of endothelial progenitor cells in tumor neovascularization. ScientificWorldJournal (2010) 0.98
CD133 expression: a potential prognostic marker for non-small cell lung cancers. Int J Clin Oncol (2013) 0.96
Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis. Cancer Res (2009) 0.93
Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells. Am J Respir Cell Mol Biol (2012) 0.89
Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks. J Cutan Pathol (2010) 0.88
Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012. Ann Am Thorac Soc (2013) 0.88
KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer. J Cancer Res Clin Oncol (2007) 0.86
Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited. Gastrointest Cancer Res (2008) 0.86
Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis. World J Surg Oncol (2015) 0.85
Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors. Angiogenesis (2010) 0.84
Mechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma. BMC Cancer (2010) 0.83
Cancer stem cells: progress and challenges in lung cancer. Stem Cell Investig (2014) 0.83
Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form. PLoS One (2014) 0.81
Endothelial progenitor cells are associated with response to chemotherapy in human non-small-cell lung cancer. J Cancer Res Clin Oncol (2011) 0.81
Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma. Int J Colorectal Dis (2012) 0.79
Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells. Int J Mol Sci (2010) 0.79
Drug-resistant colon cancer cells produce high carcinoembryonic antigen and might not be cancer-initiating cells. Drug Des Devel Ther (2013) 0.78
Time-dependent changes of plasma concentrations of angiopoietins, vascular endothelial growth factor, and soluble forms of their receptors in nonsmall cell lung cancer patients following surgical resection. ISRN Oncol (2012) 0.78
Myocardial Ischemic Subject's Thymus Fat: A Novel Source of Multipotent Stromal Cells. PLoS One (2015) 0.77
Identification of three prominin homologs and characterization of their messenger RNA expression in Xenopus laevis tissues. Mol Vis (2011) 0.77
Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas. J Neurooncol (2016) 0.76
Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines. Clin Exp Metastasis (2016) 0.76
Evaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinoma. Diagn Pathol (2017) 0.75
Endothelial progenitor cells in non-small cell lung cancer. J Clin Pathol (2005) 0.75
TIE-2 expressing monocytes in human cancers. Oncoimmunology (2017) 0.75
Lack of adrenomedullin in mouse endothelial cells results in defective angiogenesis, enhanced vascular permeability, less metastasis, and more brain damage. Sci Rep (2016) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24
AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84
Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol (2002) 7.76
Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (1989) 7.30
The new World Health Organization classification of lung tumours. Eur Respir J (2001) 6.91
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (1994) 5.54
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest (2000) 5.52
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol (2001) 4.97
Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet (1992) 3.77
In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood (2000) 3.57
Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet (2000) 3.18
Molecular and functional aspects of PECAM-1/CD31. Immunol Today (1994) 2.04
Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene (1994) 2.01
A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res (1995) 1.62
Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biol Ther (2003) 1.60
Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol (1997) 1.55
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst (1997) 1.41
Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol (1995) 1.40
Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res (1996) 1.33
Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res (2000) 1.25
Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer. Clin Cancer Res (1998) 1.21
Vascular targeting as a strategy for cancer therapy. N Engl J Med (1998) 1.14
Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol (2002) 1.09
Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann Thorac Surg (1996) 1.08
High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression. Lung Cancer (2001) 1.06
Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma. Eur J Cancer (1998) 1.04
Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma. Clin Cancer Res (1997) 0.95
Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. Ann Thorac Surg (1999) 0.90
In vivo release of vascular endothelial growth factor from colorectal carcinomas. Oncology (2002) 0.86
Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis. J Clin Pathol (2003) 0.86
Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet (2000) 3.18
Recurrence and complications after laparoscopic versus open inguinal hernia repair: results of a prospective randomized multicenter trial. Hernia (2008) 2.18
In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob Agents Chemother (1991) 1.90
Operative cholangiography in elective cholecystectomy. Br J Surg (1990) 1.75
Environmental and policy approaches to cardiovascular disease prevention through nutrition: opportunities for state and local action. Health Educ Q (1995) 1.64
The developmentally regulated type X collagen gene contains a long open reading frame without introns. J Biol Chem (1986) 1.55
The use of ultrasound to differentiate rectus sheath hematoma from other acute abdominal disorders. Surg Endosc (1999) 1.44
Time-resolved immunofluorometry and other frequently used immunoassay types for follicle-stimulating hormone compared by using identical monoclonal antibodies. Clin Chem (1993) 1.44
Detection of superficial zone protein in human and animal body fluids by cross-species monoclonal antibodies specific to superficial zone protein. Hybridoma (2001) 1.42
[The testis as eutopic production site of human growth hormone, placental lactogen and prolactin: possible autocrine/paracrine effects on testicular function]. Wien Klin Wochenschr (1996) 1.39
Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Br J Cancer (2010) 1.38
Observations from the CDC: community empowerment: CDC collaboration with the CARE Community-Based Reproductive Health Project in two districts in Tanzania. J Womens Health Gend Based Med (1999) 1.34
First experiences with the da Vinci operating robot in thoracic surgery. Eur J Cardiothorac Surg (2004) 1.28
Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol (2001) 1.27
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours. J Clin Pathol (2009) 1.26
A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). J Clin Invest (2001) 1.25
Treatment of hepatic cysts in the era of laparoscopic surgery. Br J Surg (1997) 1.25
Antisense oligonucleotides suppress cell-volume-induced activation of chloride channels. Pflugers Arch (1995) 1.21
Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol (2007) 1.20
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. Br J Cancer (2003) 1.16
Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest (2000) 1.15
An evaluation of a community-based approach to safe motherhood in northwestern Tanzania. Int J Gynaecol Obstet (2003) 1.14
Successful multivisceral transplantation. Transplant Proc (1992) 1.09
Effect of inhibitors of Na+/H+-exchange and gastric H+/K+ ATPase on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes. Br J Pharmacol (1998) 1.09
In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae. Mycoses (2002) 1.08
Nanoscale chemical imaging using top-illumination tip-enhanced Raman spectroscopy. Nano Lett (2010) 1.07
Report of the Expert Panel on Awareness and Behavior Change to the Board of Directors, American Heart Association. Circulation (1996) 1.07
Improved stabilization of conventional (Brooke) ileostomies with the stapler technique. World J Surg (1992) 1.06
Recombinant osteogenic protein-1 upregulates extracellular matrix metabolism by rabbit annulus fibrosus and nucleus pulposus cells cultured in alginate beads. J Orthop Res (2003) 1.05
Molecular and functional aspects of anionic channels activated during regulatory volume decrease in mammalian cells. Pflugers Arch (2002) 1.04
Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology (2002) 1.03
Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol (1997) 1.03
Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus. Eur J Surg Oncol (2010) 1.03
Epstein-Barr virus-associated multicentric leiomyosarcoma in an adult patient after heart transplantation: case report and review of the literature. Am J Surg Pathol (2000) 1.02
Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group. Ann Oncol (2008) 1.02
Patterns of liver infiltration in lymphoproliferative disease. Histopathology (2008) 1.02
Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer. Eur J Cancer (2003) 1.01
Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression. Acta Neuropathol (2000) 1.00
Enteropathy-associated T-cell lymphoma with initial manifestation in the CNS. Neurology (2003) 1.00
Mercury content in vegetation and soils of the Almadén mining area (Spain). Sci Total Environ (2005) 1.00
Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy. Hum Pathol (1998) 0.99
MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma. Leukemia (2012) 0.98
Na(+)/H(+)exchangers: linking osmotic dysequilibrium to modified cell function. Cell Physiol Biochem (2001) 0.98
Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis. Neurology (2000) 0.98
Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment. J Clin Pathol (2009) 0.96
Detection of homocytotropic antibody associated with a unique immunoglobulin class in the bovine species. Eur J Immunol (1971) 0.96
Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas. J Clin Pathol (2004) 0.94
Hypoxia and HIF-1alpha protect A549 cells from drug-induced apoptosis. Cell Death Differ (2006) 0.93
Bradykinin-induced oscillations of cell membrane potential in cells expressing the Ha-ras oncogene. J Biol Chem (1991) 0.93
Candida ciferrii, a new fluconazole-resistant yeast causing systemic mycosis in immunocompromised patients. Ann Hematol (2001) 0.93
Plasma cell quantification in bone marrow by computer-assisted image analysis. Histol Histopathol (2006) 0.93
Spontaneous remission in a secondary acute myelogenous leukaemia following invasive pulmonary aspergillosis. Ann Hematol (2001) 0.93
[Danger of carcinoma of the gastric stump]. Langenbecks Arch Chir (1968) 0.92
Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin. Circ Res (1997) 0.92
Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma. Pathol Res Pract (1998) 0.91
Cellular mechanisms of ATP-induced hyperpolarization in renal epitheloid MDCK-cells. J Cell Physiol (1991) 0.90
Induction of endothelial cell differentiation into capillary-like structures by substance P. Eur J Pharmacol (1996) 0.90
High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC). J Clin Pathol (2006) 0.89
Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment. Prostate (1998) 0.89
Mouse model of transplant arteriosclerosis: role of intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol (2000) 0.89
Comparison of agar versus broth dilution techniques for determining antibiotic susceptibilities of Ureaplasma urealyticum. Diagn Microbiol Infect Dis (1991) 0.89
Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin. Mycoses (2009) 0.89
Preservation of small bowel grafts--a comparison with two standard solutions. Eur Surg Res (1993) 0.89
Heat shock protein expression in the transplanted human kidney. Transpl Int (2001) 0.89
Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Ann Hematol (2003) 0.89
Robot-assisted laparoscopic partial posterior fundoplication with the DaVinci system: initial experiences and technical aspects. Langenbecks Arch Surg (2003) 0.88
Intraurethral ultrasound correlated with urethral histology. Obstet Gynecol (1998) 0.88
Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases. J Clin Pathol (2003) 0.88
An evaluation of Choose to Move 1999: an American Heart Association physical activity program for women. Arch Intern Med (2001) 0.88
Expression of superficial zone protein in mandibular condyle cartilage. Osteoarthritis Cartilage (2006) 0.87
Rejection of kidney and pancreas after pancreas-kidney transplantation. Diabetes (1989) 0.87
Primary gastrointestinal B-cell lymphoma. A clincopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters. Pathol Res Pract (2001) 0.87
Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. J Infect Dis (2000) 0.87
Intravascular large B-cell lymphoma with a fulminant clinical course: a case report with definite diagnosis post mortem. Ann Oncol (2002) 0.87
Hypoxia induces heat shock protein expression in human coronary artery bypass grafts. Cardiovasc Res (2001) 0.87
Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis. J Clin Pathol (2003) 0.86
Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease. Leukemia (2007) 0.86
Eutopic production of human chorionic gonadotropin beta (hCG beta) and luteinizing hormone beta (hLH beta) in the human testis. FEBS Lett (1994) 0.86
Contribution of endothelial cells of hematopoietic origin to blood vessel formation. Circ Res (2001) 0.86
Robot-assisted mediastinal parathyroidectomy. Surg Endosc (2004) 0.86
Phenotype and topography of human thymic B cells. An immunohistologic study. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.85
Anticoagulant-induced pseudothrombocytopenia and pseudoleucocytosis. Thromb Haemost (1995) 0.85
Serum glycoprotein hormones and their free alpha-subunit in a healthy elderly population selected according to the SENIEUR protocol. Analyses with ultrasensitive time resolved fluoroimmunoassays. Mech Ageing Dev (1993) 0.85
Systemic mastocytosis with associated myeloproliferative disease and precursor B lymphoblastic leukaemia with t(13;13)(q12;q22) involving FLT3. J Clin Pathol (2008) 0.84
Structure-function relation of a cloned epithelial chloride channel. Ren Physiol Biochem (1994) 0.84
Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil Steril (1997) 0.84
Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. Eur J Cancer (1999) 0.84
Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia. J Hematother Stem Cell Res (2002) 0.84
Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000. J Clin Pathol (2006) 0.84
Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood (1998) 0.83
Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett (1993) 0.83
Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer. Eur J Surg Oncol (2009) 0.83